Literature DB >> 28250128

Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5.

Ann E Tollefson1, Baoling Ying1, Jacqueline F Spencer1, John E Sagartz2, William S M Wold1, Karoly Toth3.   

Abstract

Syrian hamsters are permissive for the replication of species C human adenoviruses (HAdV-C). The virus replicates to high titers in the liver of these animals after intravenous infection, while respiratory infection results in virus replication in the lung. Here we show that two types belonging to species C, HAdV-C5 and HAdV-C6, replicate to significantly different extents and cause pathology with significantly different severities, with HAdV-C6 replicating better and inducing more severe and more widespread lesions. The virus burdens in the livers of HAdV-C6-infected hamsters are higher than the virus burdens in HAdV-C5-infected ones because more of the permissive hepatocytes get infected. Furthermore, when hamsters are infected intravenously with HAdV-C6, live, infectious virus can be isolated from the lung and the kidney, which is not seen with HAdV-C5. Similarly to mouse models, in hamsters, HAdV-C6 is sequestered by macrophages to a lesser degree than HAdV-C5. Depletion of Kupffer cells from the liver greatly increases the replication of HAdV-C5 in the liver, while it has only a modest effect on the replication of HAdV-C6. Elimination of Kupffer cells also dramatically increases the pathology induced by HAdV-C5. These findings indicate that in hamsters, pathology resulting from intravenous infection with adenoviruses is caused mostly by replication in hepatocytes and not by the abortive infection of Kupffer cells and the following cytokine storm.IMPORTANCE Immunocompromised human patients can develop severe, often lethal adenovirus infections. Respiratory adenovirus infection among military recruits is a serious problem, in some cases requiring hospitalization of the patient. Furthermore, adenovirus-based vectors are frequently used as experimental viral therapeutic agents. Thus, it is imperative that we investigate the pathogenesis of adenoviruses in a permissive animal model. Syrian hamsters are susceptible to infection with certain human adenoviruses, and the pathology accompanying these infections is similar to what is observed with adenovirus-infected human patients. We demonstrate that replication in permissive cells in a susceptible host animal is a major part of the mechanism by which systemic adenovirus infection induces pathology, as opposed to the chiefly immune-mediated pathology observed in nonsusceptible hosts. These findings support the use of compounds inhibiting adenovirus replication as a means to block adenovirus-induced pathology.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  adenoviruses; hamster; viral pathogenesis

Mesh:

Year:  2017        PMID: 28250128      PMCID: PMC5411597          DOI: 10.1128/JVI.00284-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus.

Authors:  Elena V Shashkova; Jacqueline F Spencer; William S M Wold; Konstantin Doronin
Journal:  Mol Ther       Date:  2006-12-26       Impact factor: 11.454

2.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

Authors:  S Worgall; G Wolff; E Falck-Pedersen; R G Crystal
Journal:  Hum Gene Ther       Date:  1997-01-01       Impact factor: 5.695

3.  A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Δ24 in advance of a phase I clinical trial in ovarian cancer patients.

Authors:  Kenneth H Kim; Michael J Ryan; James E Estep; Brock M Miniard; Thomas L Rudge; James O Peggins; Trevor L Broadt; Minghui Wang; Meredith A Preuss; Gene P Siegal; Akseli Hemminki; Raymond D Harris; Rosemarie Aurigemma; David T Curiel; Ronald D Alvarez
Journal:  Hum Gene Ther       Date:  2011-03-23       Impact factor: 5.695

4.  Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.

Authors:  Mallory A Turner; Sumit Middha; Sean E Hofherr; Michael A Barry
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

5.  Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors.

Authors:  Maria A Thomas; Jacqueline F Spencer; William S M Wold
Journal:  Methods Mol Med       Date:  2007

6.  Characterization of species C human adenovirus serotype 6 (Ad6).

Authors:  Eric A Weaver; Mathew L Hillestad; Reeti Khare; Donna Palmer; Philip Ng; Michael A Barry
Journal:  Virology       Date:  2011-01-20       Impact factor: 3.616

Review 7.  Replicative adenoviruses for cancer therapy.

Authors:  R Alemany; C Balagué; D T Curiel
Journal:  Nat Biotechnol       Date:  2000-07       Impact factor: 54.908

8.  A new animal model for human respiratory tract disease due to adenovirus.

Authors:  D L Pacini; E J Dubovi; W A Clyde
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

9.  Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.

Authors:  Sergia Bortolanza; Maria Bunuales; Itziar Otano; Gloria Gonzalez-Aseguinolaza; Carlos Ortiz-de-Solorzano; Daniel Perez; Jesus Prieto; Ruben Hernandez-Alcoceba
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

10.  Mining the adenovirus virome for oncolytics against multiple solid tumor types.

Authors:  C Y Chen; E A Weaver; R Khare; S M May; M A Barry
Journal:  Cancer Gene Ther       Date:  2011-09-02       Impact factor: 5.987

View more
  12 in total

Review 1.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses.

Authors:  Karoly Toth; Jacqueline F Spencer; Baoling Ying; Ann E Tollefson; Caroll B Hartline; Eric T Richard; Jiajun Fan; Jinglei Lyu; Boris A Kashemirov; Cheryl Harteg; Dawn Reyna; Elke Lipka; Mark N Prichard; Charles E McKenna; William S M Wold
Journal:  Antiviral Res       Date:  2018-03-03       Impact factor: 5.970

3.  Filociclovir Is a Potent In Vitro and In Vivo Inhibitor of Human Adenoviruses.

Authors:  Karoly Toth; Islam T M Hussein; Ann E Tollefson; Baoling Ying; Jacqueline F Spencer; Jessica Eagar; Scott H James; Mark N Prichard; William S M Wold; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

4.  HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.

Authors:  Karoly Toth; Jacqueline F Spencer; Baoling Ying; Ann E Tollefson; William S M Wold
Journal:  Viruses       Date:  2017-06-13       Impact factor: 5.048

5.  Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9.

Authors:  Jinxin Miao; Baoling Ying; Rong Li; Ann E Tollefson; Jacqueline F Spencer; William S M Wold; Seok-Hwan Song; Il-Keun Kong; Karoly Toth; Yaohe Wang; Zhongde Wang
Journal:  Viruses       Date:  2018-05-06       Impact factor: 5.048

6.  The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.

Authors:  Fanny Georgi; Vardan Andriasyan; Robert Witte; Luca Murer; Silvio Hemmi; Lisa Yu; Melanie Grove; Nicole Meili; Fabien Kuttler; Artur Yakimovich; Gerardo Turcatti; Urs F Greber
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

7.  Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus.

Authors:  Erika M Petro-Turnquist; Brianna L Bullard; Matthew J Pekarek; Eric A Weaver
Journal:  Vaccines (Basel)       Date:  2022-06-10

8.  Adenovirus 14p1 Immunopathogenesis during Lung Infection in the Syrian Hamster.

Authors:  Jay R Radke; Hunter J Covert; Fredrick Bauer; Vijayalakshmi Ananthanarayanan; James L Cook
Journal:  Viruses       Date:  2020-05-30       Impact factor: 5.048

9.  Generation and characterization of an I l2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients.

Authors:  Rong Li; Baoling Ying; Yanan Liu; Jacqueline F Spencer; Jinxin Miao; Ann E Tollefson; James D Brien; Yaohe Wang; William S M Wold; Zhongde Wang; Karoly Toth
Journal:  Dis Model Mech       Date:  2020-08-27       Impact factor: 5.758

Review 10.  Animal Models in Human Adenovirus Research.

Authors:  Luca D Bertzbach; Wing-Hang Ip; Thomas Dobner
Journal:  Biology (Basel)       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.